Published in Diagn Pathol on July 09, 2009
Tissue microarrays: one size does not fit all. Diagn Pathol (2010) 1.10
The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients. Diagn Pathol (2013) 0.89
c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasia. Oncotarget (2015) 0.87
[Precancerous lesions of the cervix. Biomarkers in cytological diagnosis]. Pathologe (2011) 0.83
Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia. Diagn Pathol (2014) 0.82
Effects of sulfasalazine on lipid peroxidation and histologic liver damage in a rat model of obstructive jaundice and obstructive jaundice with lipopolysaccharide-induced sepsis. Curr Ther Res Clin Exp (2009) 0.82
Detection and pathological value of papillomavirus DNA and p16(INK4A) and p53 protein expression in cervical intraepithelial neoplasia. Oncol Lett (2014) 0.81
Novel dual-function CellDetect® staining technology: wedding morphology and tinctorial discrimination to detect cervical neoplasia. Diagn Pathol (2010) 0.79
p16INK4A expression is frequently increased in periorbital and ocular squamous lesions. Diagn Pathol (2015) 0.76
Evaluation of the use of therapeutic peptides for cancer treatment. J Biomed Sci (2017) 0.75
Role of p16/INK4a and Ki-67 as specific biomarkers for cervical intraepithelial neoplasia: An institutional study. J Lab Physicians (2017) 0.75
p16 protein is upregulated in a stepwise fashion in colorectal adenoma and colorectal carcinoma. Saudi J Gastroenterol (2016) 0.75
Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med (1998) 25.41
Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A (1983) 14.73
A cell cycle regulator potentially involved in genesis of many tumor types. Science (1994) 13.00
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77
Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta (1996) 7.79
Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev (1993) 7.40
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (1994) 6.06
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol (2006) 5.86
Validation of tissue microarray technology in breast carcinoma. Lab Invest (2000) 5.50
Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol (1993) 4.67
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol (2006) 4.66
Molecular cloning of viral DNA from human genital warts. J Virol (1981) 4.50
A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer (2007) 4.29
Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer (2001) 3.61
The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene (2001) 2.77
Mutations and altered expression of p16INK4 in human cancer. Proc Natl Acad Sci U S A (1994) 2.64
Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol (1998) 2.62
Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4. Cancer Res (1994) 1.88
Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol (2006) 1.79
p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies. Pathology (2005) 1.62
New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer (2002) 1.60
p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol (2003) 1.27
p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol (2003) 1.22
Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: an immunohistochemical study. Int J Cancer (1996) 1.20
p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch (2004) 1.12
Expression and prognostic value of the cell-cycle regulatory proteins, Rb, p16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2, in ovarian cancer. Int J Gynecol Pathol (2003) 1.09
Quantitation in immunohistology: fact or fiction? A discussion of variables that influence results. Appl Immunohistochem Mol Morphol (2004) 1.07
Disruption of cell cycle control by human papillomaviruses with special reference to cervical carcinoma. Int J Gynecol Cancer (2000) 1.02
Validation of tissue microarray technology using cervical adenocarcinoma and its precursors as a model system. Int J Gynecol Cancer (2006) 0.85
Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet (2002) 3.82
Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol (2009) 3.70
Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med (2003) 2.81
In situ genotyping individual DNA molecules by target-primed rolling-circle amplification of padlock probes. Nat Methods (2004) 2.40
Genotype-guided tamoxifen therapy: time to pause for reflection? Lancet Oncol (2009) 1.65
Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma. Haematologica (2010) 1.54
A microRNA detection system based on padlock probes and rolling circle amplification. RNA (2006) 1.49
CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark. J Natl Cancer Inst (2011) 1.47
Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res (2007) 1.45
[Nonalcoholic steatohepatitis--a "new" hepatic disease]. Ugeskr Laeger (2003) 1.37
Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes. Am J Pathol (2007) 1.30
HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer. Radiother Oncol (2009) 1.28
HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci U S A (2010) 1.27
Improved diagnosis of mycobacterial infections in formalin-fixed and paraffin-embedded sections with nested polymerase chain reaction. APMIS (2005) 1.21
Increased sensitivity of KRAS mutation detection by high-resolution melting analysis of COLD-PCR products. Hum Mutat (2010) 1.12
Real-time quantitative PCR of microdissected paraffin-embedded breast carcinoma: an alternative method for HER-2/neu analysis. J Mol Diagn (2004) 1.08
Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen. Acta Oncol (2010) 1.07
Concordance of metabolic enzyme genotypes assayed from paraffin-embedded, formalin-fixed breast tumors and normal lymphatic tissue. Clin Epidemiol (2010) 1.06
The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas. Am J Pathol (2003) 1.05
Assembly and structural analysis of a covalently closed nano-scale DNA cage. Nucleic Acids Res (2007) 1.04
Comparative analysis of three- and two-antibody cocktails to AMACR and basal cell markers for the immunohistochemical diagnosis of prostate carcinoma. Diagn Pathol (2012) 0.98
Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma. Clin Cancer Res (2008) 0.97
Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry. Histopathology (2014) 0.95
Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma. Blood (2011) 0.95
Detection of single enzymatic events in rare or single cells using microfluidics. ACS Nano (2011) 0.94
Active, but not inactive, human centromeres display topoisomerase II activity in vivo. Chromosome Res (2002) 0.94
Hairpin structures formed by alpha satellite DNA of human centromeres are cleaved by human topoisomerase IIalpha. Nucleic Acids Res (2008) 0.93
Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet. Nutr Res (2012) 0.91
Single-molecule detection of human topoisomerase I cleavage-ligation activity. ACS Nano (2009) 0.91
Chronic hepatitis caused by persistent parvovirus B19 infection. BMC Infect Dis (2010) 0.91
A new enzymatic route for production of long 5'-phosphorylated oligonucleotides using suicide cassettes and rolling circle DNA synthesis. BMC Biotechnol (2007) 0.91
Droplet microfluidics platform for highly sensitive and quantitative detection of malaria-causing Plasmodium parasites based on enzyme activity measurement. ACS Nano (2012) 0.91
Multiplexed detection of site specific recombinase and DNA topoisomerase activities at the single molecule level. ACS Nano (2009) 0.90
In situ detection of non-polyadenylated RNA molecules using Turtle Probes and target primed rolling circle PRINS. BMC Biotechnol (2007) 0.90
Modification of tamoxifen response: what have we learned? J Clin Oncol (2008) 0.89
Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study. Cancer Epidemiol Biomarkers Prev (2007) 0.88
Detection of short repeated genomic sequences on metaphase chromosomes using padlock probes and target primed rolling circle DNA synthesis. BMC Mol Biol (2007) 0.86
Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms. Haematologica (2007) 0.86
Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings. Br J Haematol (2005) 0.84
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2011) 0.81
Structure of nanoscale truncated octahedral DNA cages: variation of single-stranded linker regions and influence on assembly yields. ACS Nano (2010) 0.80
Real-time detection of TDP1 activity using a fluorophore-quencher coupled DNA-biosensor. Biosens Bioelectron (2013) 0.80
Demonstration of B. burgdorferi-DNA in two cases of nodal lymphoma. Leuk Lymphoma (2004) 0.80
Lymphadenectomy in surgical stage I epithelial ovarian cancer. Acta Obstet Gynecol Scand (2014) 0.80
Laser-assisted microdissection of membrane-mounted tissue sections. Methods Mol Biol (2005) 0.80
Laser-assisted microdissection of membrane-mounted sections following immunohistochemistry and in situ hybridization. Methods Mol Biol (2005) 0.79
Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study. Acta Oncol (2011) 0.79
Fas ligand expression in metastatic renal cell carcinoma during interleukin-2 based immunotherapy: no in vivo effect of Fas ligand tumor counterattack. Clin Cancer Res (2004) 0.79
The natural history of liver regeneration in rats: description of an animal model for liver regeneration studies. Int J Surg (2013) 0.79
A narrow deletion of 7q is common to HCL, and SMZL, but not CLL. Eur J Haematol (2004) 0.78
Sorafenib inhibits liver regeneration in rats. HPB (Oxford) (2013) 0.78
Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders. Leuk Lymphoma (2015) 0.77
Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization. Cancer Genet Cytogenet (2005) 0.77
HER2/neu (c-erbB-2) gene amplification and protein expression are rare in uterine cervical neoplasia: a tissue microarray study of 814 archival specimens. APMIS (2009) 0.76
Epstein-Barr virus-associated gastric carcinoma among patients with pernicious anemia. Int J Cancer (2011) 0.76
Comment on 'Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy'. Cancer Sci (2008) 0.76
Microfluidics-mediated isothermal detection of enzyme activity at the single molecule level. Conf Proc IEEE Eng Med Biol Soc (2011) 0.76
Advanced hepatocellular carcinoma in adolescence associated with congenital cholestasis: a case description. Case Rep Oncol (2013) 0.75
Immunohistochemical detection of 3 viral infections in paraffin-embedded tissue from mink (Mustela vison): a tissue-microarray-based study. Can J Vet Res (2007) 0.75
[Hepatocellular adenoma - new classification and recommendations]. Ugeskr Laeger (2015) 0.75
[Nonalcoholic steatohepatitis. Three case reports]. Ugeskr Laeger (2003) 0.75
A Selective Biomarker Panel Increases the Reproducibility and the Accuracy in Endometrial Biopsy Diagnosis. Int J Gynecol Pathol (2017) 0.75
Multiple telomeric aberrations in a telomerase-positive leukemia patient. Cancer Genet Cytogenet (2002) 0.75
[Detection of human herpes virus 8 in Kaposi sarcoma using polymerase chain reaction and single stranded probe in situ hybridization with a tyramide signal amplification system]. Zhonghua Bing Li Xue Za Zhi (2002) 0.75
[Clear cell adenocarcinoma of the uterine cervix in a 17-year-old girl]. Ugeskr Laeger (2014) 0.75
Neuroendocrine Tumors of the Fallopian Tube: Report of a Case Series and Review of the Literature. Int J Gynecol Pathol (2017) 0.75
A different approach to telomere analysis with ddPRINS in chronic lymphocytic leukemia. Eur J Med Genet (2005) 0.75
Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma development. AIDS (2016) 0.75
[Non-alcoholic fatty liver disease in children and adolescents]. Ugeskr Laeger (2017) 0.75
Extensive cytogenetic analysis of a stable dicentric isochromosome 21, idic(21), formed by fusion of the terminal long arms. Cytogenet Genome Res (2002) 0.75